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Abstract  
A man was found dead in a hotel located near Rome (Italy). The man was still holding a syringe 
attached to a butterfly needle inserted in his left forearm vein. The syringe contained a cloudy 
pinkish fluid. In the hotel room the Police found a broken propofol glass vial plus four sealed ones, 
an opened NaCl plastic vial and six more still sealed, and a number of packed smaller disposable 
syringes and needles. An opened plastic bottle containing a white crystalline powder labelled as 
potassium cyanide was also found. Systematic toxicological analysis (STA), carried out on blood, 
urine and bile, evidenced only the presence of propofol in blood and bile. So the validated L-L 
extraction protocol and the GC/MS-TOF method for the confirmation of propofol in the biological 
fluids optimized in our laboratory was applied to blood, urine and bile. The concentration of 
propofol resulted to be 0.432 g/mL in blood and 0.786 g/mL in bile. The quantitative 
determination of cyanide in blood was carried by microdiffusion technique coupled to 
spectrophotometric detection obtaining a cyanide concentration of 5.3 g/mL. The quantitative 
determination was then confirmed by GC/NPD and  the concentration of cyanide resulted to be 5.5 
g/mL in blood and 1.7 g/mL in bile. 
Data emerging from autopsy findings, histopathological exams and the concentrations of cyanide 
suggested that death might be due to poisoning caused by cyanide, however respiratory depression 
caused by propofol could not be excluded.  
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Introduction    
A man was found dead with a broken propofol glass vial and an opened plastic bottle containing a 
white crystalline powder labelled as potassium cyanide nearby.  
Cyanide is a powerful and fast-acting toxic agent. It has also been used as a poison since ancient 
times, death occurring very rapidly (1-4). Cyanide salts (in particular sodium or potassium cyanide) 
are the most used agents for homicide or suicide attempts (5,6). Sodium and potassium cyanide 
lethal oral doses for adults are 0.15-0.3 g (5).  The average endogenous level of cyanide in blood is 
0.059 g/mL for non-smokers and 0.123 g/mL for smokers. So blood cyanide concentrations 
lower than 0.25 g⁄mL are considered normal, and those above 0.25 g⁄mL but below 2.00–3.00 
g⁄mL as elevated, but not ordinarily causing death. In fire cases, the average blood concentration is 
reported to be 1.12 g/mL. On the other hand concentrations found in suicide cases range from 1.00 
to 53.00 g/mL (average of 12.40 g/mL). (7-9). There is no consensus on the precise toxic 
threshold for cyanide, but concentrations above 1 g/mL are generally considered toxic (10). 
Propofol (2,6-diisopropylphenol) is one of the most widely used drugs in surgery (11); it is injected 
intravenously for induction and maintenance of anesthesia and for conscious sedation in intensive 
care patients (12). The blood concentration required for induction of anesthesia is generally 2-10 
mg/L, while a concentration of 2-4 mg/L is sufficient to maintain it (13-15). Propofol is also 
associated with abuse and dependency, especially among health care professionals (16-18). Fatal 
cases of poisoning caused by propofol reported in the literature (17-25) show a high variability in 
the blood concentration of propofol (from 0.08 to 8.7 mg/L) (14). 
Systematic and toxicological analysis (STA) (24) applied on blood, urine and bile collected from 
the autopsy evidenced only the presence of propofol (Fig. 1), excluding other volatile or non-
volatile organic compounds. For the quantitative determination of propofol on the three biological 
fluids, the method optimized in our laboratory was applied (25). The determination of cyanide (26-
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40) was carried out by the microdiffusion technique with spectrophotometric determination 
previously developed in our laboratory by Froldi-Gambaro (41) which was optimized; in particular 
attention was devoted to the preparation of the reagents. This method is very important because it is 
easily applicable when chromatographic techniques are not available.  Data were then confirmed by 
HS-GC coupled with an NPD detector due to the reliability of this technique (41). 
 
Case history 
 
A 33-year old male was found dead by the chambermaid of a hotel located in a small town by the 
sea, South of Rome (Italy). 
The man was lying on the bed; he was fully dressed except for the belt and the shoes, no trauma 
was evidenced. He was still holding in his right hand a 20 cc syringe attached to a butterfly needle 
inserted in his left forearm vein. The syringe contained about 10 cc of a cloudy pinkish fluid, 
identified as propofol. The man was an orthoptist from a Northern Italian region who worked in an 
eye clinic in Milan. In the hotel room the Police found a broken propofol glass vial – 10 mg/mL, 20 
cc - plus four sealed ones, an opened NaCl 0.9% plastic vial and six more still sealed, and a number 
of packed smaller disposable syringes and needles. On the tabletop there was an opened plastic 
bottle containing a white crystalline powder labelled as potassium cyanide. 
Due to the unclear circumstances of the death, the body was made available to the judiciary. The 
autopsy was performed 72 hours after. 
According to further investigative results, the man worked in Milan as an orthoptist in an eye clinic. 
He leaved home (Scapaccino near Asti town in northern Italy) at 8.00 p.m. on the 21
st
 of October 
2015, he drove for 711 km to reach Anzio near Rome. The man had ordered on the Internet 
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potassium cyanide. Analyses confirmed that the crystalline powder was effectively potassium 
cyanide.  
 
Autopsy Findings 
 
External examination of the body showed fixed pink lividity of the face, chest, scrotum and a 
venipuncture sign at the lower third of the left forearm. 
Nothing relevant at the autopsy, except for signs of parenchymal congestion and edema of the 
brain, liver and lungs revealed when cut. 
The pericardial sac was undamaged and the heart had a normal volume; the endocardium was thin; 
the myocardium was red and his consistency was not increased. The coronary arteries were of 
normal size and elastic. The blood was fluid. 
Arterial blood (3 mL), bile (3 mL), urine (2 mL) were collected from the autopsy and stored as 
indicated in ref 41.  
 
Materials and methods 
 
Reagents, chemicals and standards 
 
All reagents were of analytical grade and were stored as indicated by the supplier. pH 6 buffer, 
barbituric acid for spectrophotometric determination of cyanide > 99.5% were purchased from 
Sigma-Aldrich (St. Louis, MO, USA);  
Potassium cyanide (KCN) standard was purchased from Carlo Erba Reagents (Rodano, 
Italy). Acetonitrile (IS), chloramine T trihydrate, H2SO4, NaOH, NaH2PO4 and HCl were purchased 
from J.T. Backer (Deventer, Holland). Pyridine, glacial acetic acid were purchased from Fluka 
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(Buchs, Switzerland). Water (18.2 M·cm-1) was prepared by a Milli-Q System (Millipore, 
Darmstadt, Germany); other common chemicals were of the highest purity commercially available. 
Pyridine-barbituric acid reagent was prepared as follows:  2.0 g barbituric acid were placed 
in a flask, 25 mL of water were added, the mixture was stirred until dissolution at 80 °C (5 min). 2 
mL of concentrated HCl were dropped into the mixture and then 10 mL of pyridine were added. 
The solution is stable for one month at 4 °C. 
 
Sample preparation and extraction procedure for the analysis of propofol 
 
Blood (1 mL), urine (1 mL) or bile (250 L) was added with IS (100 L, 10 g/mL), 
physiological solution (until a volume of 2 mL was reached), 50 mg of a mixture of sodium 
bicarbonate and carbonate (2/1 w/w) and extracted with ethyl acetate (4 mL). The mixture was 
put on a rotary shaker (20 min, 15 rpm) and then centrifuged (5 min, 5000 rpm). The organic 
phase was separated, dried with sodium sulfate and after centrifugation (5 min, 5000 rpm) the 
supernatant was withdrawn and the solvent evaporated with a gentle stream of nitrogen (40 
°C). The residue was dissolved in ethyl acetate (100 L) before the analysis. 
Tissue samples were homogenized with a blender or ball mill, depending on the quantity of 
material. The deproteinization of the biological matrix was performed by means of an ultrasonic 
bath: 100 mg of tissue (brain, liver or kidney) previously added with 4 mL of physiological  
solution, 50 mg of a mixture of sodium bicarbonate and carbonate (2/1 w/w) and 100 µL of IS 
(10 g/mL) were sonicated for 15 minutes at room temperature. After 5 min centrifugation, a clear 
supernatant was separated and extracted with ethyl acetate (4 mL). The mixture was placed on a 
rotary shaker (20 min, 15 rpm) and then centrifuged (5 min, 5000 rpm). The organic phase was 
separated, dried with anhydrous sodium sulfate and after centrifugation (5 min, 5000 rpm) the 
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supernatant was withdrawn and the solvent evaporated with a gentle stream of nitrogen (40 
°C). The residue was dissolved in ethyl acetate (100 L) before the analysis. 
 
Hydrolysis of propofol glucuronide and sulfate in urine and bile samples 
 
The sample of urine (1 mL) or bile (250 L) was added with saline solution until a volume 
of 2 mL  and 1 mL of 6N hydrochloric acid was added. The mixture was heated at 105 °C for 1 h. 
After cooling, IS (100 L, 10 g/mL) and 50 mg of a mixture of sodium bicarbonate and 
carbonate (2/1 w/w) were added. Then the mixtures were extracted as described before.  
 
 
GC/MS-TOF analysis of propofol 
 
The analyses were performed on a Dani Master GC system, with a split-splitless injection 
system and a Dani Master TOF Plus detector (Dani Instruments, Cologno Monzese, Italy) operated 
in electron ionization (EI) mode (70 eV). The GC was equipped with a Rxi
®
-5ms (Crossbond
®
,5% 
diphenyl/95% dimethyl polysiloxane, 10 m x 0.10 mm i.d., film thickness 0.15 m) capillary 
column (Restek, Bellefonte, PA, USA). 
The GC/MS conditions: split ratio 100:1; injector temperature, 250°C; interface transfer line, 
280°C; ion source, 200°C; oven temperature program, initial 70°C, 20°C/min up to 200°C, then 
30°C/min up to 300°C (17 s). Helium was used as the carrier gas at a flow rate of 0.5 mL/min. The 
MS detector was operated in the scan mode, acquiring ions from m/z 50 to 550. The total analysis 
time was 8 min. The selected ions for quantitative analysis were 163 and 178 for propofol and 135 
and 150 for the IS (Fig. 1). 
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Microdiffusion 
 
Glass Conway microdiffusion cells were used (18 ・ 70 mm o.d.; 8–10 ・ 41 mm o.d., inner 
chamber). Adsorbing solution (2 mL, 0.1 M NaOH) was added to the inner compartment of each 
Conway cell, and the liberating solution (2 mL, 50% H2SO4) was added to the outer compartment. 
Blood (100 L blood + 900 L of 0.1 N NaOH), standard (100 L of standard solution + 900 L of 
0.1 N NaOH) or blank samples (100 L of physiological solution + 900 L of 0.1 N NaOH) were 
added to the opposite part of the outer chamber, as mixing had to be avoided. The cell was then 
quickly closed by a Teflon-lined screw cap and gently rotated to mix blood and liberating solution. 
After 30 min contact at 38 °C, 1 mL of the inner chamber contents from each cell was taken up and 
transferred into a 10 mL volumetric flask. To each flask 3 mL of 1 M KH2PO4 and 1 mL of 
Chloramine-T (2.5 g ⁄L, freshly prepared) were added, mixed, and allowed to stand for 2–3 min. 
Pyridine-barbituric acid reagent (3 mL) was then added and the solution diluted to 10 mL with H2O. 
Absorbance was determined at 585 nm against a blank. 
 
Spectrophotometric Analysis 
 
UV-Visible determinations were performed on a Varian CARY50 (Torino, Italy) 
Spectrophotometer. Standard cyanide solution was prepared by placing 25.0 mg of KCN in a 100 
mL volumetric flask, to yield a solution with a concentration of 100 g⁄mL of cyanide; 0.1 N NaOH 
was used as diluent. The standard cyanide solution was further diluted to yield six working 
solutions at concentrations in the range of 0.2–5.0 g⁄mL of cyanide.  
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HS-GC ⁄NPD analysis of cyanide 
 
Apparatus—Automated headspace GC analysis was carried out on a ThermoFinningan Trace TG, 
equipped with an NP detector 850, and interfaced with an autosampler (all from ThF, Rodano, 
Italy). A 10 mL vial and a 2.5 mL Hamilton 1002 NTL headspace syringe (Hamilton Co, Reno, NV, 
U.S.A.) were used. After addition of acetic acid to the sample vial, the autosampler moved the vial 
from the vial tray holder to the sample heater, where the vial was heated at 60 °C with continuous 
agitation for 40 min. Using a thermostated syringe, 750 L of headspace vapor was injected into the 
GC inlet at a split rate of 40:1. Injector temperature was 100 °C. Gas chromatographic separation 
took place in a PoraBOND U fused-silica capillary column (30 m ・ 0.32 mm i.d., 7 m film 
thickness) (Varian, Torino, Italy). Purified helium was used as carrier gas, at constant pressure to 
assure a steady column flow rate of 2.0 mL⁄ min. Detector gas flow rate was set at 60 and 3 
mL⁄min for hydrogen and air, respectively. Column temperature was programmed at 90 °C for 5 
min and increased by 10 °C⁄m in to a final temperature of 140 °C. Detector temperature was 300 
°C. In these chromatographic conditions, retention times (tR) were about 1.62 and 3.57 min for 
cyanide and IS, respectively. (Fig. 2). 
Standard cyanide solution was prepared by placing 25.0 mg of KCN in a 100 mL volumetric flask 
to yield a solution with a concentration of 100 g⁄mL of CN; 0.1 N NaOH was used as diluent. In 
another volumetric flask, 5 mL of this was transferred and added with 95 mL of 0.1 N NaOH to 
yield a solution with a concentration of 5 g⁄mL. Standard cyanide solution was further diluted to 
yield six working solutions at a concentration in the range of 5.0–0.1 g⁄mL. Approximately, 0.5 
mL of each solution was transferred into a 10 mL vial together with 0.5 mL of IS and 0.5 mL of 
blank blood. Lastly, 50 L of glacial acetic acid was then introduced through the silicone rubber 
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with a microsyringe. Internal standard solution was prepared by placing 1 mL acetonitrile in a 100 
mL volumetric flask and diluting with water. This solution was then further diluted to yield a 
solution with a final concentration of 0.005 g⁄mL. Preliminary analysis of samples revealed high 
concentrations of cyanide, so that the blood samples had to be suitably diluted to yield 
concentrations in a calibration range. 1mL of each blood samples was diluted in a 10 mL volumetric 
flask with water. Therefore, 0.5 mL each of diluted sample, IS, and 0.1 N NaOH 
were placed in a 10 mL glass vial, which was then capped with teflon-coated silicone rubber and 
sealed by crimping an aluminium cap. An aliquot (50 L) of glacial acetic acid was introduced 
through the silicone rubber with a microsyringe. After each injection, the syringe was flushed many 
times with air to ensure no carry-over of residual cyanide. Blank air injections were also routinely 
run between samples to avoid this problem completely. 
 
Results 
Linearity of the microdiffusion method was assessed in the range 0.2 – 5.0 g/mL (0.2, 0.4, 0.8, 2.0, 
3.0, 5.0 g/mL) of cyanide. The linearity equation was y = 0.3256x + 0.0032 (R2= 0.998). The 
concentration of cyanide calculated with the microdiffusion method was 5.3 g⁄mL. 
Analyses carried out by HS-GC ⁄NPD (41) confirmed the presence of cyanide giving a blood 
concentration of 5.5 g⁄mL, value comparable with that obtained by microdiffusion. With this 
method the presence of cyanide in bile was also evidenced (1.7 g⁄mL). On the contrary cyanide 
was not evidenced in urine.  
 Analysis of propofol by GC/MS-TOF (25) evidenced a concentration of 0.432 and 0.786 
g⁄mL respectively in blood and bile, while urine resulted negative.  
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Discussion  
The microdiffusion method, previously developed by Froldi-Gambaro (41), was optimized to 
improve accuracy and sensitivity. Particular attention had to be paid to the barbituric acid used for 
this determination. 2.0 g instead of 3.0 g were used in the optimized method, dissolved in 25 mL of 
water instead of 7 mL of water, thus improving the dissolution of the reagent. The reagent must be 
dissolved under stirring at 80 °C. Working with more diluted solutions is very important because 
the absorbance of the standard solutions follows in the range of the linearity of the instrument. With 
the more concentrated solutions the response of the instrument was slightly outside the range and 
therefore the spectrophotometric determinations were less accurate. The purity of this reagent is 
crucial. The best reagent was that labelled as “barbituric acid for spectrophotometric determination 
of cyanide > 99.5%”. 
The sensitivity of the optimized method was improved respect to the previous one. In fact the LOQ 
of the previous method was 0.5 g/mL working with 1 mL of sample, in the optimized method the 
LOQ is 0.2 g/mL, working with 100 L of sample. In the new method LOD was established to be 
0.1 g/mL working with 100 L of sample, lower than the LOD of the previous method (0.2 
g/mL, working with 1 mL of sample). Working with 1 mL of blood the LOD and LOQ of the 
optimized method are respectively 0.01 and 0.02 g/mL. Thus the increase of sensitivity was 
meaningful. Moreover with the new LOD and LOQ it is possible to work with 100 L of blood, this 
was not possible with the previous method. This feature is very important because in forensic 
analysis 1 mL of blood is not always available.  
The optimized microdiffusion method was applied to the determination of cyanide in blood collected 
from the autopsy of the case reported. The results were confirmed applying the HS-GC/NPD (41) 
method (Fig. 2). As regard as blood, the two techniques gave comparable results (Table 1). Due to 
its high sensitivity the HS-GC/NPD method allowed the determination of cyanide in bile. As it is 
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possible to note propofol concentration in blood (Fig. 3) was quite low (0.432 g/mL) and likely it 
was not responsible for death (11-23). On the other hand the blood concentration of cyanide was 
very high (5.3-5.5 g/mL). Taking into account literature data (1-10) it was possible to assess that 
death was caused by cyanide, however respiratory depression caused by propofol without 
respiratory support could not be axcluded.  
Probably the man had planned suicide, in fact he left a farewell letter and a fair amount of money. 
Because working in the medical field he knew the properties of propofol. Likely he ingested 
cyanide and then injected himself propofol, withdrawing it from the glass vial labelled as “propofol 
kabi 10 mg/mL”. As cyanide poisoning causes nausea, confusion, restlessness and anxiety followed 
by loss of consciousness, convulsions and fatal shock, probably the man assumed propofol to avoid 
cyanide symptoms. In fact propofol causes sedation, loss of consciousness and anesthesia in a very 
short period of time.  
 
 
Conclusions 
 
The microdiffusion method for the determination of cyanide in blood previously developed in our 
laboratory was optimized and applied to a case of suspected cyanide/propofol poisoning. The 
presence of propofol in the biological fluids was confirmed by a GC/MS-TOF method. The 
quantitative determination of cyanide in blood carried by the microdiffusion technique coupled to 
spectrophotometric analysis was then confirmed by GC/NPD analysis.  
Data emerging from autopsy findings, histopathological exams and the high concentration of 
cyanide (5.3-5.5 g/mL) suggested that death might be due to poisoning caused by cyanide, 
however propofol could have had a role in death due to its toxicity without respiratory support.  
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Figure legends 
Fig. 1 SCAN analysis of blood (a); Mass spectrum of propofol-TMS (b) 
Fig. 2 HS-GC/NPD of blood.  
Fig. 3 (A) GC/MS-TOF chromatogram for the determination of propofol in blood;  tR=2,830 min 
IS; tR=3,273 min Propofol-ME B) Mass spectrum of methylated thymol (IS); C) Mass spectrum of 
methylated propofol. 
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Table 1. Results of the quantitative determination of cyanide and propofol in the specimens 
 
Specimen 
Cyanide (g/mL) Propofol 
(g/mL) Microdiffusion HS-GC/NPD 
Blood 5.3 5.5 0.432 
Bile  n.e. 1.7 0.786 
Urine n.e. n.e. n.d 
n.e. = not examined; n.d. = not detectable. 
 
